SironRX Raises $3.4 Million: BioEnterprise

» Overview
» Team
» Companies
» Initiatives
» Cleveland+
» Newsroom

Media Contact
Annette Ballou
Email
216.658.3999

SironRX, a Cleveland-based regenerative medicine company that develops wound-healing therapies licensed from Juventas Therapeutics and Cleveland Clinic, has raised $3.4 million from a syndicate that includes Fletcher Spaght Ventures, North Coast Angel Fund, Early Stage Partners, JumpStart, Ohio Tech Angel Fund, and Glengary. Funds will be used to conduct clinical trials to evaluate the safety and efficacy of the company's lead product, JVS-100.

Click here to read more from Crain's Cleveland.

Recent News

Great Lakes NeuroTechnologies Receives $4.5 Million

Life Core Technologies Raises Seed Funding

Research Organics acquired by Sigma-Aldrich

CardioInsight Raises $7.5 Million

ViewRay Raises $16 Million

The 2012 Venture Report

Cleveland:
Health Care Innovation Destination

Add me to your emailing list: sign up

Cleveland Medical Mart & Convention Center

The world’s only convention facility created for the health care industry.
» View More

BioEnterprise : 11000 Cedar Avenue, Cleveland, OH 44106 | 216.658.3999